Copycat weight loss drugs, Amazon's pharmacies, and CVS vs. Lina Khan: Pharma news roundup
If Medicare were to start covering popular weight loss drugs such as Wegovy and Zepbound, it could increase federal spending by billions of dollars, according to a new report by the Congressional Budget Office (CBO). Amazon says that it plans to open pharmacies in 20 new cities across the U.S. in 2025. And some companies are fighting back against Eli Lilly and the U.S. Food and Drug Administration’s (FDA) recent moves to keep them from selling off-brand weight loss drugs.
Check out those stories and more pharmaceutical news highlights from this week.
Knockoff weight loss drug sellers are fighting back against Eli Lilly and the FDA
Eli Lilly is calling on companies that have been selling off-brand versions of its popular diabetes and weight-loss drugs during widespread shortages to halt production now that supplies are stabilizing. But some of these companies aren’t backing down without a fight.
Amazon is doubling down on pharmacies
Amazon wants to give more customers access to same-day delivery for their prescriptions. The company announced on Wednesday that it plans to open pharmacies in 20 new cities across the U.S. in 2025.
Offering Wegovy and other weight loss drugs on Medicare could cost $35 billion
Allowing Medicare to cover popular weight loss drugs such as Wegovy and Zepbound could increase federal spending by billions of dollars, according to a new report by the Congressional Budget Office.
CVS and UnitedHealth want FTC Chair Lina Khan to recuse herself from a case over insulin prices
CVS and UnitedHealth Group on Tuesday demanded that Federal Trade Commission (FTC) Chair Lina Khan and two other commissioners recuse themselves from the agency’s lawsuit against the companies, accusing them of “blatant bias.”
Medicare wants to make these generic drugs available for just $2
The Centers for Medicare and Medicaid Services just shared a preliminary list of generic drugs it plans to make available to Medicare recipients for $2 in a pilot program.
Ozempic and prescription weight loss drugs: How they work, what they cost, side effects, and everything to know
A highly effective class of weight loss drugs has taken the world by storm, as medications like Ozempic, Wegovy, and Zepbound become household names. This guide will break down everything you need to know about these drugs, their differences, how they work, and their potential side effects.
WeightWatchers is getting in on the off-brand weight loss drug game — and selling them cheap
WeightWatchers announced Tuesday that it is now offering off-brand weight loss drugs for one of the cheapest prices in the industry.
Kamala Harris wants Medicare to help cover in-home eldercare. Here’s how she plans to pay for it
Vice President Kamala Harris is proposing to expand Medicare benefits for home care services for elders. Her campaign says the proposal will be funded by savings generated from Harris’ plans for lowering government spending on prescription drug prices.